{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:17:40Z","timestamp":1783739860250,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.jaci.2004.09.007","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T11:54:11Z","timestamp":1100001251000},"page":"1010-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mechanistic actions of the risks and adverse events associated with vaccine administration"],"prefix":"10.1016","volume":"114","author":[{"given":"Edina H.","family":"Moylett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Celine","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.09.007_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1359","article-title":"The promise of cancer vaccines","volume":"4","author":"Gilboa","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaci.2004.09.007_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/14760584.1.4.443","article-title":"Current advances in antifertility vaccines for fertility control and noncontraceptive applications","volume":"1","author":"Ferro","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaci.2004.09.007_bib3","first-page":"27","article-title":"Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines","volume":"6","author":"Karin","year":"2004","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.jaci.2004.09.007_bib4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0140-6736(91)92034-Y","article-title":"Central-nervous-system demyelination after immunization with recombinant hepatitis B vaccine","volume":"338","author":"Herroelen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.09.007_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.53.2.396","article-title":"Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?","volume":"53","author":"Tourbah","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2004.09.007_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/08916930290028175","article-title":"Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM","volume":"35","author":"Classen","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaci.2004.09.007_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1515\/JPEM.2003.16.4.495","article-title":"Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals","volume":"16","author":"Classen","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jaci.2004.09.007_bib8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/art.1780390913","article-title":"Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program","volume":"39","author":"Weibel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2004.09.007_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/thx.53.11.927","article-title":"Early childhood infection and atopic disorder","volume":"53","author":"Farooqi","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2004.09.007_bib10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0140-6736(96)91617-7","article-title":"Measles and atopy in Guinea-Bissau","volume":"347","author":"Shaheen","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.09.007_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0264-410X(99)00533-2","article-title":"Is there a causal link between hepatitis B vaccination and multiple sclerosis?","volume":"18","author":"Monteyne","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.09.007_bib13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJMoa032665","article-title":"Childhood vaccination and type 1 diabetes","volume":"350","author":"Hviid","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.09.007_bib14","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/S0264-410X(03)00302-5","article-title":"The pertussis vaccine controversy in Great Britain, 1974-1986","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/bmj.282.6276.1595","article-title":"Pertussis immunisation and serious acute neurological illness in children","volume":"282","author":"Miller","year":"1981","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2004.09.007_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.09.007_bib17","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.1982.03330190042028","article-title":"Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults","volume":"248","author":"Myers","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.09.007_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0022172400022750","article-title":"Reactions to tetanus toxoid","volume":"71","author":"White","year":"1973","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.jaci.2004.09.007_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/infdis\/144.4.376","article-title":"Tetanus toxoid: what determines reaction proneness?","volume":"144","author":"Levine","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2004.09.007_bib20","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM196112072652307","article-title":"Adult immunization II: dosage reduction as a solution to increasing reactions to tetanus toxoid","volume":"265","author":"McComb","year":"1961","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.09.007_bib21","first-page":"574","article-title":"Reactions to tetanus toxoid: comparison of fluid and adsorbed toxoids","volume":"64","author":"Holden","year":"1965","journal-title":"N Z Med J"},{"key":"10.1016\/j.jaci.2004.09.007_bib22","first-page":"430","article-title":"Reactions to tetanus toxoid","volume":"62","author":"Relihan","year":"1969","journal-title":"J Ir Med Assoc"},{"key":"10.1016\/j.jaci.2004.09.007_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","article-title":"Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines","volume":"14","author":"Rennels","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.jaci.2004.09.007_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.410180308","article-title":"Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981","volume":"18","author":"Beghi","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaci.2004.09.007_bib25","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1994.03510440062034","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.09.007_bib26","first-page":"809","article-title":"Allergic reactions to tetanus, diphtheria, influenza and poliomyelitis immunization","volume":"20","author":"Smith","year":"1962","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2004.09.007_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1982.03320260024022","article-title":"Adverse reactions to tetanus toxoid","volume":"247","author":"Jacobs","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.09.007_bib28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(86)92194-X","article-title":"Diphtheria vaccine for adults","volume":"2","author":"Mortimer","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.09.007_bib29","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1542\/peds.106.4.e51","article-title":"Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)","volume":"106","author":"Braun","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0387-7604(03)00169-4","article-title":"An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines","volume":"26","author":"Geier","year":"2004","journal-title":"Brain Dev"},{"key":"10.1016\/j.jaci.2004.09.007_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(82)90041-9","article-title":"Bordetella pertussis toxins","volume":"19","author":"Wardlaw","year":"1982","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaci.2004.09.007_bib32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1345\/aph.1A410","article-title":"Clinical implications of endotoxin concentrations in vaccines","volume":"36","author":"Geier","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaci.2004.09.007_bib33","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.69.7.4217-4223.2001","article-title":"Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1\u03b2 in a new murine model for analysis of neuronal side effects of vaccination","volume":"69","author":"Donnelly","year":"2001","journal-title":"Infect Immunol"},{"key":"10.1016\/j.jaci.2004.09.007_bib34","first-page":"993","article-title":"Progress toward eliminating haemophilus influenzae type b disease among infants and children\u2014United States, 1987-1997","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib35","first-page":"203","article-title":"Notice to Readers: FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (Pediarix\u2122) for use in infants","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib36","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1542\/peds.108.6.e112","article-title":"Childhood vaccinations, vaccination timing and risk of type 1 diabetes mellitus","volume":"108","author":"DeStefano","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib37","first-page":"1","article-title":"Preventing Pneumococcal disease among infants; recommendations of the Advisory Committee on Immunization Practices","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib38","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.09.007_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0264-410X(03)00521-8","article-title":"Revaccination with the 23-valent pneumococcal vaccine in middle-aged and elderly persons previously treated for pneumonia","volume":"22","author":"Torling","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1532-5415.2003.51064.x","article-title":"Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence and safety in frail, chronically ill older subjects","volume":"51","author":"Lackner","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jaci.2004.09.007_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1542\/peds.106.2.367","article-title":"Technical report: prevention of pneumococcal infection including the use of pneumococcal conjugate vaccine and polysaccharide vaccines and antibiotic prophylaxis","volume":"106","author":"American Academy of Pediatrics: Committee on Infectious Diseases","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib42","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.vaccine.2004.01.061","article-title":"Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type","volume":"22","author":"Rimaniol","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib43","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archderm.1984.01650460058020","article-title":"Injection site granuloma due to aluminum","volume":"120","author":"Fawcett","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2004.09.007_bib44","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.1995.01690240085014","article-title":"Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts","volume":"131","author":"Garcia-Patos","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2004.09.007_bib45","first-page":"177","article-title":"Immediate hypersensitivity reactions to immunotherapy","volume":"13","author":"Can","year":"2003","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2004.09.007_bib46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8561(03)00095-X","article-title":"Aluminum inclusion macrophagic myofasciitis: a recently identified condition","volume":"23","author":"Gheraradi","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2004.09.007_bib47","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0264-410X(03)00013-6","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants","volume":"21","author":"Zangwill","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib48","first-page":"532","article-title":"Progress toward global eradication of poliomyelitis, January 2000-April 2004","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0031-3955(05)70208-X","article-title":"Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States","volume":"47","author":"Sutter","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaci.2004.09.007_bib50","first-page":"128","article-title":"MMR vaccine and neomycin allergy","volume":"147","author":"Kwittken","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2004.09.007_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0889-8561(03)00099-7","article-title":"Vaccine allergy: diagnosis and management","volume":"23","author":"Madaan","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2004.09.007_bib52","first-page":"157","article-title":"Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and health vaccines","volume":"40","author":"Friedrich","year":"1996","journal-title":"Acta Virol"},{"key":"10.1016\/j.jaci.2004.09.007_bib53","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaci.2004.09.007_bib54","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency disease in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaci.2004.09.007_bib55","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"53","author":"Harper","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","article-title":"Influenza vaccination and Guillain-Barre syndrome, small star, filled","volume":"107","author":"Geier","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2004.09.007_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3476(98)70101-5","article-title":"Safe administration of influenza vaccine to patients with egg allergy","volume":"133","author":"James","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2004.09.007_bib58","first-page":"35","article-title":"Immunization of egg-allergic individuals with egg-or chicken-derived vaccines","volume":"23","author":"Kelso","year":"2003","journal-title":"Imunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2004.09.007_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10408369708998098","article-title":"The toxicology of mercury","volume":"134","author":"Clarkson","year":"1997","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jaci.2004.09.007_bib60","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.290.13.1763","article-title":"Association between thimerosal-containing vaccine and autism","volume":"290","author":"Hviid","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.09.007_bib61","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(02)11682-5","article-title":"Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study","volume":"360","author":"Pichichero","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.09.007_bib62","series-title":"Immunization safety review: vaccines and autism","author":"Immunization Safety Review Committee","year":"2004"},{"key":"10.1016\/j.jaci.2004.09.007_bib63","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1542\/peds.107.5.1147","article-title":"An assessment of thimerosal use in childhood vaccines","volume":"107","author":"Ball","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1542\/peds.110.4.662","article-title":"Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children","volume":"110","author":"Piedra","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib65","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.vaccine.2003.08.034","article-title":"A post-licensure study of the safety of inactivated hepatitis vaccine (VAQTA, Merck) in children and adults","volume":"s22","author":"Black","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0536.1993.tb03376.x","article-title":"The sensitizing potency of Euxyl K 400 and its components 1,20debromo-2, 4-dicyanobutane and 2-phenoxyethanol","volume":"28","author":"Hausen","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaci.2004.09.007_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14740338.2.3.225","article-title":"Safety of immunisation and adverse events following vaccination against hepatitis B","volume":"2","author":"Duclos","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaci.2004.09.007_bib69","unstructured":"World Health Organization; Vaccines, immunization and biologicals. Measles global annual reported incidence and MCV coverage, 1980-2002. Available at: http:\/\/www.who.int\/vaccines-surveillance\/graphics.htm. Accessed August 26, 2004."},{"key":"10.1016\/j.jaci.2004.09.007_bib70","first-page":"713","article-title":"Epidemiology of measles\u2014United States, 2001-2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2004.09.007_bib72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.1997.03550070043036","article-title":"Risk of chronic arthropathy among women after rubella vaccination","volume":"278","author":"Ray","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.09.007_bib73","series-title":"2003 Red Book\u2014report of the Committee on Infectious Diseases","author":"Committee on Infectious Diseases","year":"2003"},{"key":"10.1016\/j.jaci.2004.09.007_bib74","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1542\/peds.110.6.e71","article-title":"Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after Measles-Mumps-Rubella vaccine in the United States","volume":"220","author":"Pool","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib75","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0264-410X(99)00480-6","article-title":"IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines","volume":"18","author":"Sakaguchi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2004.09.007_bib76","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib77","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001-2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib78","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0091-6749(87)80156-2","article-title":"Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine","volume":"79","author":"Warrington","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.09.007_bib79","first-page":"1","article-title":"Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib80","first-page":"106","article-title":"Update: adverse events following civilian smallpox vaccination\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2004.09.007_bib81","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2004.05.004","article-title":"Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination","volume":"44","author":"Eckart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaci.2004.09.007_bib82","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia na\u00efve US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.09.007_bib83","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/382510","article-title":"Adverse events after smallpox vaccinations are associated with alterations in systemic cytokine levels","volume":"189","author":"Rock","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2004.09.007_bib84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2004.09.007_bib85","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1542\/peds.110.6.e67","article-title":"Intussusception, rotavirus and oral vaccines: summary of a workshop","volume":"110","author":"Myers","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.09.007_bib86","series-title":"Multiple immunizations and immune dysfunction. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention","first-page":"152","year":"2002"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167490402398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167490402398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:54:23Z","timestamp":1758776063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167490402398X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S009167490402398X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.09.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic actions of the risks and adverse events associated with vaccine administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}